Active ingredientVoclosporinCat. No. P-V057-001CAS 515814-01-4Family · Pharmaceutical analytical standards
Voclosporin
A calcineurin inhibitor and analogue of ciclosporin, discovered in the 1990s and approved for lupus nephritis in the United States in 2021 and in the European Union in 2022. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was the first oral treatment for lupus nephritis approved in the United States; compared with ciclosporin it changes the side chain of just one amino acid, which alters how it binds its target.
Go to the active ingredient →Active ingredientVoclosporinCat. No. P-V057-001CAS 515814-01-4
MetaboliteVoclosporin M1 MetaboliteCat. No. P-V057-002
Isotopically labelledVoclosporin-d3Cat. No. P-V057-003
Isotopically labelledVoclosporin-d4Cat. No. P-V057-004
NitrosamineN-Nitroso Iso VoclosporinCat. No. P-V057-005
NitrosamineN-Nitroso VoclosporinCat. No. P-V057-006
ImpurityIso VoclosporinCat. No. P-V057-007
ImpurityVoclosporin Impurity 1Cat. No. P-V057-008
ImpurityVoclosporin Impurity 2 (Mixture of Diastereomers)Cat. No. P-V057-010
ImpurityVoclosporin Impurity 3Cat. No. P-V057-011
ImpurityVoclosporin Impurity 4Cat. No. P-V057-012
ImpurityVoclosporin Impurity 5Cat. No. P-V057-013
ImpurityVoclosporin Impurity 6Cat. No. P-V057-014
ImpurityVoclosporin Impurity 7Cat. No. P-V057-015
ImpurityVoclosporin Impurity 8Cat. No. P-V057-016
ImpurityVoclosporin Z-isomerCat. No. P-V057-018CAS 121584-34-7
ImpurityVoclosporin Impurity 10 (VCSM004)Cat. No. P-V057-019
ImpurityVoclosporin Impurity 11 (VCSR013)Cat. No. P-V057-020
ImpurityVoclosporin Impurity 12 (VCSR023)Cat. No. P-V057-021
ImpurityVoclosporin Impurity 13 (VCSR037)Cat. No. P-V057-022No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.